(DX2X) Xtrackers - Stoxx Europe - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0328475792
DX2X: European, Large-Cap, Blend, Equity
The Xtrackers - Stoxx Europe600 UCITS ETF is designed to track the performance of the STOXX Europe600 Index, providing investors with broad exposure to 600 companies across 18 European countries, encompassing large, medium, and small-cap stocks. The Indexs composition is reviewed quarterly, ensuring it remains a representative benchmark of the European equity market.
The ETF achieves its objective by replicating the Index through the purchase of a substantial number of constituent shares in proportion to their weighting in the Index, as determined by Deutsche Asset Management (UK) Limited. The Index is calculated on a total return net basis, meaning that dividends and distributions are reinvested after tax, thereby maximizing the compounding effect for investors.
From a technical standpoint, the ETFs price action indicates a bullish trend, with the short-term Simple Moving Average (SMA20) at 139.22, closely aligned with the last price of 139.12. The medium-term SMA50 at 133.63 and long-term SMA200 at 130.94 suggest a positive trajectory, as the short-term average is above both the medium and long-term averages. The Average True Range (ATR) of 1.21, or 0.87%, indicates moderate volatility.
Given the current technical and fundamental data, a forecast for the DX2X ETF can be formulated. With the AUM at 1586.28M EUR, the ETF demonstrates a significant presence in the market. The proximity of the last price to the 52-week high of 140.18, coupled with the bullish SMA alignment, suggests potential for further growth. However, the relatively modest ATR indicates that significant price movements may be driven more by fundamental factors, such as changes in the European equity market or shifts in investor sentiment, rather than technical volatility.
Based on these insights, a potential forecast could involve a continued upward trajectory, with the ETF potentially challenging or exceeding its current 52-week high, driven by the overall performance of the European equity market and the STOXX Europe600 Index. Investors should monitor changes in the Index composition, macroeconomic indicators, and overall market sentiment to adjust their strategies accordingly.
Additional Sources for DX2X ETF
DX2X ETF Overview
Market Cap in USD | 3,562m |
Category | Europe Large-Cap Blend Equity |
TER | 0.20% |
IPO / Inception | 2009-01-20 |
DX2X ETF Ratings
Growth Rating | 70.2 |
Fundamental | - |
Dividend Rating | 2.39 |
Rel. Strength | -6.54 |
Analysts | - |
Fair Price Momentum | 132.43 EUR |
Fair Price DCF | - |
DX2X Dividends
Currently no dividends paidDX2X Growth Ratios
Growth Correlation 3m | 71.8% |
Growth Correlation 12m | 66% |
Growth Correlation 5y | 89.4% |
CAGR 5y | 10.83% |
CAGR/Max DD 5y | 0.52 |
Sharpe Ratio 12m | 1.39 |
Alpha | -1.82 |
Beta | 0.544 |
Volatility | 13.44% |
Current Volume | 17.6k |
Average Volume 20d | 15k |
As of July 01, 2025, the stock is trading at EUR 137.16 with a total of 17,610 shares traded.
Over the past week, the price has changed by +1.30%, over one month by -1.08%, over three months by +2.97% and over the past year by +8.55%.
Yes. Based on ValueRay´s Analyses, Xtrackers - Stoxx Europe (XETRA:DX2X) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.21 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DX2X is around 132.43 EUR . This means that DX2X is currently overvalued and has a potential downside of -3.45%.
Xtrackers - Stoxx Europe has no consensus analysts rating.
According to our own proprietary Forecast Model, DX2X Xtrackers - Stoxx Europe will be worth about 149.5 in July 2026. The stock is currently trading at 137.16. This means that the stock has a potential upside of +8.96%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 149.5 | 9% |